Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

(2014) H. R. Ali et al.   ANNALS OF ONCOLOGY

C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

(2014) Laure Dossus et al.   CANCER CAUSES & CONTROL

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

(2014) Krasimira Aleksandrova et al.   HEPATOLOGY

Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1  Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression

(2014) T. Nishikawa et al.   JOURNAL OF IMMUNOLOGY

Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer

(2014) Jinpu Yu et al.   JOURNAL OF IMMUNOLOGY

Prognostic Influence of Pre-Operative C-Reactive Protein in Node-Negative Breast Cancer Patients

(2014) Isabel Sicking et al.   PLoS One

Association Between C-reactive Protein and Risk of Cancer: A Meta-analysis of Prospective Cohort Studies

(2013) Yong-Zhong Guo et al.   Asian Pacific Journal of Cancer Prevention

Iron metabolism and risk of cancer in the Swedish AMORIS study

(2013) Anjali Gaur et al.   CANCER CAUSES & CONTROL

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

(2013) Anna E. Prizment et al.   CANCER CAUSES & CONTROL

Postdiagnosis C-Reactive Protein and Breast Cancer Survivorship: Findings from the WHEL Study

(2013) A. Villasenor et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Proteomic Changes Induced by Effective Chemopreventive Ratios of n-3:n-6 Fatty Acids and Tamoxifen against MNU-Induced Mammary Cancer in the Rat

(2013) C. G. Skibinski et al.   Cancer Prevention Research

Obesity Promotes Breast Cancer by CCL2-Mediated Macrophage Recruitment and Angiogenesis

(2013) L. M. Arendt et al.   CANCER RESEARCH

CD4+ follicular helper T cell infiltration predicts breast cancer survival

(2013) Chunyan Gu-Trantien et al.   JOURNAL OF CLINICAL INVESTIGATION

Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

(2013) Sherene Loi et al.   JOURNAL OF CLINICAL ONCOLOGY

The Stat3 paradox: A killer and an oncogene

(2013) Henrike K. Resemann et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial

(2013) Mittie K. Doyle et al.   RHEUMATOLOGY

Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury

(2013) Jürgen Borlak et al.   Genome Medicine

Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study

(2012) M. Touvier et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Elevation in Inflammatory Serum Biomarkers Predicts Response to Trastuzumab-Containing Therapy

(2012) Ahmed A. Alkhateeb et al.   PLoS One

Association between Levels of C-Reactive Protein and Leukocytes and Cancer: Three Repeated Measurements in the Swedish AMORIS Study

(2011) M. Van Hemelrijck et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer

(2011) Paul Dowling et al.   INTERNATIONAL JOURNAL OF CANCER

STAT3/NF-κB interactions determine the level of haptoglobin expression in male rats exposed to dietary restriction and/or acute phase stimuli

(2011) Aleksandra Uskoković et al.   MOLECULAR BIOLOGY REPORTS

Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

(2010) Ingar Holme et al.   ATHEROSCLEROSIS

Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation

(2010) Mieke Van Hemelrijck et al.   INTERNATIONAL JOURNAL OF CANCER

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

(2009) Brandon L. Pierce et al.   JOURNAL OF CLINICAL ONCOLOGY

Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer

(2009) Kristine H. Allin et al.   JOURNAL OF CLINICAL ONCOLOGY

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

NF-κB and cancer: how intimate is this relationship

(2009) Sahdeo Prasad et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

(2008) Katriina Heikkilä et al.   CANCER CAUSES & CONTROL

SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL

(2008) Johanna L. Barclay et al.   INTERNATIONAL JOURNAL OF CANCER

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET